Twist Bioscience Corp. (TWST)
140.74
-4.85
(-3.33%)
USD |
NASDAQ |
Aug 24, 16:00
138.00
-2.74
(-1.95%)
After-Hours: 19:54
Twist Bioscience Debt to Equity Ratio : 0.21 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.21 |
| March 31, 2026 | 0.2106 |
| December 31, 2025 | 0.215 |
| September 30, 2025 | 0.1598 |
| June 30, 2025 | 0.1634 |
| March 31, 2025 | 0.1825 |
| December 31, 2024 | 0.1812 |
| September 30, 2024 | 0.1799 |
| June 30, 2024 | 0.1775 |
| March 31, 2024 | 0.1597 |
| December 31, 2023 | 0.1557 |
| September 30, 2023 | 0.1509 |
| June 30, 2023 | 0.1415 |
| March 31, 2023 | 0.1296 |
| December 31, 2022 | 0.1259 |
| September 30, 2022 | 0.1202 |
| June 30, 2022 | 0.0958 |
| March 31, 2022 | 0.0923 |
| Date | Value |
|---|---|
| December 31, 2021 | 0.1165 |
| September 30, 2021 | 0.1083 |
| June 30, 2021 | 0.1044 |
| March 31, 2021 | 0.052 |
| December 31, 2020 | 0.0534 |
| September 30, 2020 | 0.107 |
| June 30, 2020 | 0.1087 |
| March 31, 2020 | 0.1532 |
| December 31, 2019 | 0.4163 |
| September 30, 2019 | 0.0508 |
| June 30, 2019 | 0.048 |
| March 31, 2019 | 0.0793 |
| December 31, 2018 | 0.0711 |
| September 30, 2018 | 0.1091 |
| June 30, 2018 | 0.0996 |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | 0.1381 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Beam Therapeutics, Inc. | 0.2317 |
| Prime Medicine, Inc. | 2.825 |
| Intellia Therapeutics, Inc. | 0.1009 |
| 10X Genomics, Inc. | 0.0954 |
| Generate Biomedicines, Inc. | 0.1373 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 672.44M |
| Total Liabilities (Quarterly) | 226.70M |
| Shareholders Equity (Quarterly) | 445.74M |
| Current Ratio | 2.672 |
| Net Debt Paydown Yield | -0.04% |